JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...

Healthcare Analysts discus what’s new and what is on the horizon for Non-Tuberculosis Mycobacteria Lung Disease (relevant companies ANTX INSM ...

JMP Securities has reaffirmed its Market Outperform rating and a price target of $41.00 on Exelixis stock (NASDAQ:EXEL), aligning with the broader analyst consensus that sees upside potential.

JMP Securities analyst Steven DeLaney lowered the firm’s price target on Redwood Trust (RWT) to $8 from $9 and keeps an Outperform rating on ...

Orchid Island Capital Inc (ORC) stock saw a decline, ending the day at $7.94 which represents a decrease of $-0.08 or -1.00% from the prior close of $8.02. The stock opened at $8.01 and touched a low ...

On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.24 or -7.59% from the prior close of $3.16. The stock opened at $3.17 and ...

JMP Securities restated their market outperform rating on shares of BlackLine (NASDAQ:BL – Free Report) in a research report released on Wednesday morning,Benzinga reports. The firm currently has a ...

JMP Securities restated their market outperform rating on shares of Churchill Downs (NASDAQ:CHDN – Free Report) in a report ...

Benchmark believes that Roku can benefit meaningfully from establishing partnerships with other platforms and further ...

JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending antitrust litigation.The firm believes the Department of Justice case ...

JMP Securities analyst Mitch Germain upgraded Broadstone Net Lease (BNL) to Outperform from Market Perform with a $21 price target The firm believes progress from the company’s portfolio ...

https://www.tipranks.com/news/the-fly/clearmind-medicine-to-move-forward-with-meai-based-alcohol-substitute JMP Securities raised the firm’s price target on Mirum ...